In this sleep-focused episode, Dr. Christine Palmay and Dr. Jeff Habert discuss the latest advancements in insomnia treatment, breaking down the real impact of this chronic health issue on daily function, mental health, and long-term well-being. The duo explore the rise of Dual Orexin Receptor Antagonists (DORAs), the value of cognitive behavioural therapy for insomnia (CBT-I), and why viewing insomnia as a daytime disorder can improve outcomes.

Join primary care physicians Dr. Christine Palmay and Dr. Jeff Habert as they share practical patient management strategies and clinical pearls to enhance your family medicine practice.

For more information, visit primarycareconversations.com and explore resources related to each episode at primarycareconversations.com/en-ca/en/references-resources.

This podcast is made possible through financial support from Amgen, Eisai, Lilly, Pfizer, and Bausch Health.